Overview

Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

Status:
Completed
Trial end date:
2017-06-16
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine and Rosuvastatin Co-administration in Hypertensive Patients with Hyperlipidemia
Phase:
Phase 3
Details
Lead Sponsor:
IlDong Pharmaceutical Co Ltd
Treatments:
Amlodipine
Rosuvastatin Calcium
Telmisartan
Telmisartan amlodipine combination